Alpharma Inc News Today

Processa Pharmaceuticals’ (NASDAQ: PCSA) shares skyrocketed by over 260% from their October lows of $0.18 per share. Shares peaked at $0.65 on November 14th and more recently has consolidated around $0.43. The reason for this surge was not immediately clear given the lack of material  events. However upon digging deeper, we’ve uncovered a very interesting […]

Processa Pharmaceuticals, Inc. announces that industry veteran George Ng has been appointed to serve as the Companys Chief Executive Officer and as a Board Director as of August 8, 2023. Dr. David...

Ron Rocca to Become Chief Executive Officer...

Aquaculture Therapeutics Market is likely to reach US$ 4190.3 Mn by 2032, up from US$ 1634.8 Mn in 2022 | FMI

CHARLESTON – Janssen settled with West Virginia, but the state trial continues against opioid suppliers Teva, Cephalon and Allergen continues.